NCT04192539View on ClinicalTrials.gov

The Prospect of Using Serum Taurine Level as a Potential Biomarker for Early Detection of Colorectal Carcinoma and Its Correlation With Other Prognostic Markers

NACompletedINTERVENTIONAL

Enrollment

116

Participants

Timeline

Start Date

January 18, 2017

Primary Completion Date

February 20, 2018

Study Completion Date

December 17, 2018

Conditions

Taurine in Cancer Colon

Interventions

DIAGNOSTIC_TEST

Taurine

Serum taurine was determined by High Performance Liquid Chromatography (HPLC) according to the pre-column extraction and derivatization methodology of McMahon et al. In the present work, we use Shimadzu HPLC model LC-10AT

Trial Locations (1)

Unknown

Hanaa El Gendy, Cairo

All Listed Sponsors

lead

Ain Shams University

OTHER

NCT04192539 - The Prospect of Using Serum Taurine Level as a Potential Biomarker for Early Detection of Colorectal Carcinoma and Its Correlation With Other Prognostic Markers | Biotech Hunter | Biotech Hunter